Koers Anhui Anke Biotechnology (Group) Co., Ltd.
Aandelen
300009
CNE100000GY2
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
9,55 CNY | +2,91% | -1,34% | -6,56% |
Omzet 2024 * | 3,64 mld. 503 mln. 471 mln. | Omzet 2025 * | 4,24 mld. 585 mln. 547 mln. | Marktkapitalisatie | 16,48 mld. 2,27 mld. 2,13 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 990 mln. 137 mln. 128 mln. | Nettowinst (verlies) 2025 * | 1,17 mld. 162 mln. 152 mln. | EV/omzet 2024 * | 4,72 x |
Nettoschuld 2024 * | 730 mln. 101 mln. 94,27 mln. | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 3,89 x |
K/w-verhouding 2024 * |
16,2
x | K/w-verhouding 2025 * |
13,6
x | Werknemers | 2.986 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 89,59% |
1 dag | +2,91% | ||
1 week | -1,34% | ||
Lopende maand | -1,75% | ||
1 maand | -2,85% | ||
3 maanden | +8,03% | ||
6 maanden | -1,75% | ||
Lopend jaar | -6,56% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Li Hua Song
CEO | Chief Executive Officer | 67 | 01-05-93 |
Xian Yu Du
CHM | Chairman | 54 | - |
Jian Ping Yao
PSD | President | 52 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Hui Zhao
BRD | Director/Board Member | 50 | 09-04-07 |
Li Hua Song
CEO | Chief Executive Officer | 67 | 01-05-93 |
Li Ming Song
BRD | Director/Board Member | 62 | 01-08-03 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
24-04-24 | 9,55 | +2,91% | 24 318 920 |
23-04-24 | 9,28 | -5,98% | 52 929 300 |
22-04-24 | 9,87 | +1,02% | 18 471 600 |
19-04-24 | 9,77 | -0,71% | 13 287 280 |
18-04-24 | 9,84 | +1,65% | 13 952 820 |
slotkoers Shenzhen S.E., 24 april 2024
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-6,56% | 2,2 mld. | |
-2,86% | 87,31 mld. | |
+3,95% | 40,86 mld. | |
-21,94% | 29,36 mld. | |
+57,03% | 24,49 mld. | |
-5,41% | 17,31 mld. | |
-17,60% | 11,62 mld. | |
-13,96% | 11,31 mld. | |
-44,23% | 11,26 mld. | |
+5,92% | 8,31 mld. |